{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T18:10:55Z","timestamp":1790273455737,"version":"4.1.0"},"reference-count":30,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"2024 Heilongjiang Province Medical and Health Research Projects","award":["20240303010135"],"award-info":[{"award-number":["20240303010135"]}]},{"DOI":"10.13039\/501100005046","name":"Natural Science Foundation of Heilongjiang Province","doi-asserted-by":"publisher","award":["PL2025H054"],"award-info":[{"award-number":["PL2025H054"]}],"id":[{"id":"10.13039\/501100005046","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Hypertrophic cardiomyopathy (HCM) patients exhibit heightened susceptibility to atrial fibrillation (AF), yet the underlying genetic nexus remains poorly defined. This study aimed to identify genes common to HCM and AF, thereby revealing the underlying pathogenesis of susceptibility to AF in HCM patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Genes associated with HCM and AF were sourced from the Gene Expression Omnibus (GEO), Online Mendelian Inheritance in Man (OMIM), Comparative Toxicogenomics Database (CTD), GeneCards, and DisGeNET databases. We conducted a comparative analysis to identify overlapping genes between HCM and AF for further investigation, which included functional enrichment analysis, protein-protein interaction networks, and immune infiltration assessment. Key hub genes were determined using cytoHubba, a Cytoscape plugin, and their validation was performed using independent datasets GSE36961 and GSE115574. The genes corroborated by these datasets were additionally validated in clinical samples.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 11 overlapping genes were identified between HCM and AF. Functional enrichment and immune infiltration analyses revealed their involvement in immune regulation and inflammatory processes. Three hub genes\n                      <jats:italic>NPPA<\/jats:italic>\n                      ,\n                      <jats:italic>ACE<\/jats:italic>\n                      , and\n                      <jats:italic>POMC<\/jats:italic>\n                      were recognized as key molecular links between HCM and AF. Validation using the GSE36961 dataset confirmed the upregulation of\n                      <jats:italic>NPPA<\/jats:italic>\n                      in HCM, supporting its potential as a central gene connecting the two conditions. Consistent with the bioinformatics findings, exploratory clinical verification findings of serum levels of N-terminal fragment of A-type natriuretic peptide (NT-proANP), encoded by\n                      <jats:italic>NPPA<\/jats:italic>\n                      , were markedly elevated in both the HCM and HCM with AF groups compared with healthy controls (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.01). Moreover, NT-proANP concentrations were significantly higher in the HCM\u2009+\u2009AF group than in the HCM-only group (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.01).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      This study identifies a shared genetic link between HCM and AF. The findings strongly associate elevated NT-proANP levels, encoded by the\n                      <jats:italic>NPPA<\/jats:italic>\n                      gene, with AF in HCM patients. We propose NT-proANP as a promising circulating biomarker for stratifying AF risk in this patient population.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0357969","type":"journal-article","created":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T17:44:16Z","timestamp":1790271856000},"page":"e0357969","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Shared genetic architecture of HCM and AF: Elevated NPPA\/ANP is linked to atrial electrical remodeling"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-0702-8861","authenticated-orcid":true,"given":"A. Z. M. Fahim","family":"Siddique","sequence":"first","affiliation":[{"name":"The First Affiliated Hospital of Harbin Medical University","place":["Harbin, China"],"department":["Department of Cardiology"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinru","family":"Wang","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Harbin Medical University","place":["Harbin, China"],"department":["Department of Cardiology"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruyi","family":"Du","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Harbin Medical University","place":["Harbin, China"],"department":["Department of Cardiology"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchen","family":"Wang","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Harbin Medical University","place":["Harbin, China"],"department":["Department of Cardiology"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Wang","sequence":"additional","affiliation":[{"name":"Beidahuang Industry Group General Hospital","place":["Harbin, China"],"department":["Department of Cardiology"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Guo","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Harbin Medical University","place":["Harbin, China"],"department":["Department of Geriatrics"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1997-9549","authenticated-orcid":true,"given":"Tiankai","family":"Li","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Harbin Medical University","place":["Harbin, China"],"department":["Department of Cardiology"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,9,24]]},"reference":[{"issue":"4","key":"pone.0357969.ref001","first-page":"409","article-title":"Atrial fibrillation in hypertrophic cardiomyopathy: Pathophysiology, diagnosis and management","volume":"10","author":"G Falasconi","year":"2020","journal-title":"Am J Cardiovasc Dis"},{"key":"pone.0357969.ref002","doi-asserted-by":"crossref","first-page":"101210","DOI":"10.1016\/j.jacadv.2024.101210","article-title":"Atrial fibrillation in hypertrophic cardiomyopathy","volume":"3","author":"A Weissler-Snir","year":"2024","journal-title":"JACC Adv"},{"issue":"11","key":"pone.0357969.ref003","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1093\/europace\/euw295","article-title":"2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"18","author":"P Kirchhof","year":"2016","journal-title":"Europace"},{"issue":"19","key":"pone.0357969.ref004","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1136\/heartjnl-2016-310720","article-title":"Impact of atrial fibrillation on the clinical course of apical hypertrophic cardiomyopathy","volume":"103","author":"S-E Lee","year":"2017","journal-title":"Heart"},{"key":"pone.0357969.ref005","article-title":"Hypertrophic cardiomyopathy and atrial fibrillation: A review","volume":"14","author":"V Palyam","year":"2022","journal-title":"Cureus"},{"issue":"10","key":"pone.0357969.ref006","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.echo.2005.06.011","article-title":"Enlarged left atrial volume in hypertrophic cardiomyopathy: A marker for disease severity","volume":"18","author":"H Yang","year":"2005","journal-title":"J Am Soc Echocardiogr"},{"key":"pone.0357969.ref007","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.116.004052","article-title":"Left atrial size and function in hypertrophic cardiomyopathy patients and risk of new-onset atrial fibrillation","volume":"10","author":"P Debonnaire","year":"2017","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"2","key":"pone.0357969.ref008","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.114.002769","article-title":"Association of left atrial function and left atrial enhancement in patients with atrial fibrillation: Cardiac magnetic resonance study","volume":"8","author":"M Habibi","year":"2015","journal-title":"Circ Cardiovasc Imaging"},{"issue":"6","key":"pone.0357969.ref009","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.3390\/jcm14062018","article-title":"Predicting new-onset atrial fibrillation in hypertrophic cardiomyopathy: A review","volume":"14","author":"MM Dicorato","year":"2025","journal-title":"J Clin Med"},{"issue":"11","key":"pone.0357969.ref010","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: A software environment for integrated models of biomolecular interaction networks","volume":"13","author":"P Shannon","year":"2003","journal-title":"Genome Res"},{"key":"pone.0357969.ref011","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/978-1-4939-7493-1_12","article-title":"Profiling tumor infiltrating immune cells with CIBERSORT","volume":"1711","author":"B Chen","year":"2018","journal-title":"Methods Mol Biol"},{"issue":"3","key":"pone.0357969.ref012","doi-asserted-by":"crossref","DOI":"10.1002\/imt2.36","article-title":"Sangerbox: A comprehensive, interaction-friendly clinical bioinformatics analysis platform","volume":"1","author":"W Shen","year":"2022","journal-title":"Imeta"},{"issue":"39","key":"pone.0357969.ref013","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: The Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC)","volume":"35","author":"Authors\/Task Force members","year":"2014","journal-title":"Eur Heart J"},{"key":"pone.0357969.ref014","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.2147\/JIR.S454446","article-title":"Unveiling immune infiltration characterizing genes in hypertrophic cardiomyopathy through transcriptomics and bioinformatics","volume":"17","author":"J Gong","year":"2024","journal-title":"J Inflamm Res"},{"issue":"7","key":"pone.0357969.ref015","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/jce.12982","article-title":"High incidence of de novo and subclinical atrial fibrillation in patients with hypertrophic cardiomyopathy and cardiac rhythm management device","volume":"27","author":"I Wilke","year":"2016","journal-title":"J Cardiovasc Electrophysiol"},{"key":"pone.0357969.ref016","doi-asserted-by":"crossref","DOI":"10.1016\/S0002-9149(99)00251-9","article-title":"Familial hypertrophic cardiomyopathy and atrial fibrillation caused by Arg663His beta-cardiac myosin heavy chain mutation","volume":"83","author":"EJ Gruver","year":"1999","journal-title":"Am J Cardiol"},{"issue":"3","key":"pone.0357969.ref017","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.yjmcc.2006.06.072","article-title":"Alterations in contractile protein composition and function in human atrial dilatation and atrial fibrillation","volume":"41","author":"S Eiras","year":"2006","journal-title":"J Mol Cell Cardiol"},{"issue":"9862","key":"pone.0357969.ref018","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S0140-6736(12)60397-3","article-title":"Hypertrophic cardiomyopathy","volume":"381","author":"BJ Maron","year":"2013","journal-title":"Lancet"},{"issue":"2","key":"pone.0357969.ref019","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s11886-001-0041-x","article-title":"Clinical significance of atrial fibrillation in hypertrophic cardiomyopathy","volume":"3","author":"I Olivotto","year":"2001","journal-title":"Curr Cardiol Rep"},{"issue":"11","key":"pone.0357969.ref020","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1161\/CIRCULATIONAHA.114.008788","article-title":"Immune cell and other noncardiomyocyte regulation of cardiac hypertrophy and remodeling","volume":"131","author":"RA Frieler","year":"2015","journal-title":"Circulation"},{"issue":"1","key":"pone.0357969.ref021","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1210\/er.2005-0014","article-title":"Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions","volume":"27","author":"LR Potter","year":"2006","journal-title":"Endocr Rev"},{"issue":"5","key":"pone.0357969.ref022","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1253\/circj.68.444","article-title":"Neurohumoral profiles in patients with hypertrophic cardiomyopathy: Differences to hypertensive left ventricular hypertrophy","volume":"68","author":"K Ogino","year":"2004","journal-title":"Circ J"},{"issue":"3","key":"pone.0357969.ref023","doi-asserted-by":"crossref","DOI":"10.1152\/ajpheart.00110.2005","article-title":"Tachycardia-induced myocardial ischemia and diastolic dysfunction potentiate secretion of ANP, not BNP, in hypertrophic cardiomyopathy","volume":"290","author":"S Kido","year":"2006","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"2","key":"pone.0357969.ref024","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1161\/01.RES.62.2.191","article-title":"Atrial stretch, not pressure, is the principal determinant controlling the acute release of atrial natriuretic factor","volume":"62","author":"BS Edwards","year":"1988","journal-title":"Circ Res"},{"issue":"15","key":"pone.0357969.ref025","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1053\/euhj.2000.2535","article-title":"Determinants and clinical significance of natriuretic peptides and hypertrophic cardiomyopathy","volume":"22","author":"C Briguori","year":"2001","journal-title":"Eur Heart J"},{"issue":"2","key":"pone.0357969.ref026","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1161\/01.CIR.88.2.372","article-title":"Ventricular expression of brain natriuretic peptide in hypertrophic cardiomyopathy","volume":"88","author":"K Hasegawa","year":"1993","journal-title":"Circulation"},{"key":"pone.0357969.ref027","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ijcard.2013.11.042","article-title":"Atrial natriuretic peptide as a predictor of atrial fibrillation in a male population study. The Study of Men Born in 1913 and 1923","volume":"171","author":"Z Mandalenakis","year":"2014","journal-title":"Int J Cardiol"},{"issue":"2","key":"pone.0357969.ref028","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s00392-018-1332-1","article-title":"Independent effect of atrial fibrillation on natriuretic peptide release","volume":"108","author":"M Sramko","year":"2018","journal-title":"Clinical Research in Cardiology"},{"key":"pone.0357969.ref029","article-title":"Atrial fibrillation: Genetic architecture and polygenic risk prediction","author":"S Yuan","year":"2026","journal-title":"Heart"},{"issue":"12","key":"pone.0357969.ref030","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1016\/j.amjmed.2025.07.004","article-title":"\u201cLone Atrial Fibrillation\u201d is a Four Letter Word","volume":"138","author":"JA Reiffel","year":"2025","journal-title":"Am J Med"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0357969","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T17:44:21Z","timestamp":1790271861000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0357969"}},"subtitle":[],"editor":[{"given":"Giuseppe","family":"Limongelli","sequence":"first","affiliation":[{"name":"University of Campania","place":["ITALY"]}],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,9,24]]},"references-count":30,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9,24]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0357969","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,24]]}}}